Expression of IL2, IL6, IL10, IL14, IL16, IL23, IL35, and TGFB1 was detected in topo I-reactive CD27+ B cells from anti-topo I antibody-positive SSc patients (Figure 1C). Here, IL16 is linked to systemic sclerosis.